[Characteristics of MRI features in Alzheimer's disease patients predicting response to donepezil treatment].

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics

• Publication date

  2003-05-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.3143/GERIATRICS.40.261PMID 12822478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates

  2012cited by this paper
• Regional Cerebral Blood Flow Patterns and Response to Donepezil Treatment in Patients with Alzheimer’s Disease

  2003cited by this paper
• Magnetization Transfer Ratio in Mild Cognitive Impairment and Dementia of Alzheimer's Type

  2002cited by this paper
• MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.

  2002cited by this paper
• Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease.

  2002cited by this paper
• Magnetization transfer measurements of the hippocampus in the early diagnosis of Alzheimer's disease.

  2001cited by this paper
• Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease.

  2000cited by this paper
• Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia.

  2000cited by this paper
• Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease.

  2000cited by this paper
• Assessing individual patients for cognitive benefits from acetylcholinesterase inhibitors.

  1999cited by this paper
• Cholinergic markers in elderly patients with early signs of Alzheimer disease.

  1999cited by this paper
• The presence of leuko-araiosis in patients with Alzheimer's disease predicts poor tolerance to tacrine, but does not discriminate responders from non-responders.

  1997cited by this paper
• Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease

  1997cited by this paper
• Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease?

  1996cited by this paper
• MR anatomy of the substantia innominata and findings in Alzheimer disease: a preliminary report.

  1995cited by this paper
• Hippocampal atrophy, acute THA treatment and memory in Alzheimer's disease.

  1995cited by this paper
• Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.

  1994cited by this paper
• The Lewy-Body Variant of Alzheimer's Disease

  1993cited by this paper
• Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

  1992cited by this paper
• Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease.

  1990cited by this paper
• MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

  1987cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Hippocampal atrophy but not white-matter changes predicts the long-term cognitive response to cholinesterase inhibitors in Alzheimer’s disease

  2015cites this paper
• Magnetization transfer ratio may be a surrogate of spongiform change in human prion diseases.

  2010cites this paper
• Use of SVM Methods with Surface-Based Cortical and Volumetric Subcortical Measurements to Detect Alzheimer's Disease

  2010cites this paper
• Donepezil in Alzheimer’s disease: From conventional trials to pharmacogenetics

  2007cites this paper
• [Automatic extraction of corpus callosum from midsagittal head MR image and examination of Alzheimer-type dementia objective diagnostic system in feature analysis].

  2004cites this paper